Lead optimization is a critical phase in the drug discovery pipeline, especially in cancer research. This process involves refining a lead compound, which has shown potential in preliminary screening, to improve its efficacy, selectivity, pharmacokinetics, and safety profile. The ultimate goal is to develop a candidate suitable for clinical trials.
